Skip to main content
. 2013 Jul 2;305(4):E540–E548. doi: 10.1152/ajpendo.00143.2013

Table 4.

Palmitate and oleate enrichments in the morning and afternoon biopsy in both males and females

Males
Females
Morning Afternoon Morning Afternoon
Plasma free fatty acid 13C enrichment, MPE
Oleate 0.182 ± 0.021 (n = 21) 0.196 ± 0.024 (n = 20)
imTG-fatty acid 13C enrichment, MPE
Palmitate 0.021 ± 0.002 (n = 20) 0.020 ± 0.001 (n = 20) 0.017 ± 0.002 (n = 21) 0.015 ± 0.002 (n = 21)
Oleate 0.010 ± 0.000** (n = 20) 0.012 ± 0.001 (n = 20) 0.008 ± 0.001* (n = 19) 0.009 ± 0.001 (n = 19)
im Long chain acyl-carnitine fatty acid 13C enrichment, MPE
Palmitoyl 0.016 ± 0.002 (n = 20) 0.017 ± 0.002 (n = 20) 0.014 ± 0.002 (n = 19) 0.015 ± 0.003 (n = 19)
Oleoyl 0.001 ± 0.001* (n = 20) 0.002 ± 0.001 (n = 20) 0.001 ± 0.000* (n = 19) 0.002 ± 0.001 (n = 19)
imNEFA fatty acid 13C enrichment, MPE
Palmitate 0.020 ± 0.003* (n = 13) 0.018 ± 0.002 (n = 13) 0.022 ± 0.002* (n = 19) 0.020 ± 0.002 (n = 19)
Oleate 0.008 ± 0.001** (n = 13) 0.012 ± 0.002 (n = 13) 0.005 ± 0.001** (n = 19) 0.008 ± 0.002 (n = 19)

Values are means ± SE; n, no. of subjects. The plasma oleate enrichments are those from the final 30 min of the insulin clamp. MPE, moles percent enrichment; im, intramyocellular.

*

P < 0.05 between A.M. and P.M. sample;

**

P < 0.01 between morning and afternoon samples.